Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Dominguez

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 19, 2019
Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disordersÁngela López-Sainz, F Javier de Haro-Del Moral, Fernando Dominguez, et al.
International Journal of Cardiology|August 17, 2017
Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillationFernando Dominguez, Vicente Climent, Esther Zorio, et al.
European Heart Journal. Cardiovascular Imaging|January 8, 2021
Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis RegistryKatarzyna Mizia-Stec, Philippe Charron, Juan Ramon Gimeno Blanes, et al.
ACS Nano|June 1, 2021
Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic CardiomyopathyCarmen Suay-Corredera, Maria Rosaria Pricolo, Diana Velázquez-Carreras, et al.
Nefrologia|March 14, 2021
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapyMarian Goicoechea, Francisco Gomez-Preciado, Silvia Benito, et al.
European Journal of Heart Failure|March 2, 2026
Clinical characteristics and outcomes of cardiomyopathies related to immune-mediated diseasesValentina A Rossi, Maurits A Sikking, Alessandro Folgheraiter, et al.
Nefrologia|September 27, 2022
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapyMarian Goicoechea, Francisco Gomez-Preciado, Silvia Benito, et al.
European Heart Journal|November 6, 2020
Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differencesJob A J Verdonschot, Marco Merlo, Fernando Dominguez, et al.
Circulation|March 31, 2026
MR-ProADM Predicts Mortality and Heart Failure Events in ATTR Cardiac AmyloidosisBelén Peiró-Aventín, Elena Revuelta-Lopez, Mariana Brandao, et al.
International Journal of Neonatal Screening|October 19, 2020
CCHD Screening Implementation Efforts in Latin American Countries by the Ibero American Society of Neonatology (SIBEN)Augusto Sola, Susana Rodríguez, Alejandro Young, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 19, 2019
Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disordersÁngela López-Sainz, F Javier de Haro-Del Moral, Fernando Dominguez, et al.
International Journal of Cardiology|August 17, 2017
Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillationFernando Dominguez, Vicente Climent, Esther Zorio, et al.
European Heart Journal. Cardiovascular Imaging|January 8, 2021
Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis RegistryKatarzyna Mizia-Stec, Philippe Charron, Juan Ramon Gimeno Blanes, et al.
ACS Nano|June 1, 2021
Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic CardiomyopathyCarmen Suay-Corredera, Maria Rosaria Pricolo, Diana Velázquez-Carreras, et al.
Nefrologia|March 14, 2021
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapyMarian Goicoechea, Francisco Gomez-Preciado, Silvia Benito, et al.
European Journal of Heart Failure|March 2, 2026
Clinical characteristics and outcomes of cardiomyopathies related to immune-mediated diseasesValentina A Rossi, Maurits A Sikking, Alessandro Folgheraiter, et al.
Nefrologia|September 27, 2022
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapyMarian Goicoechea, Francisco Gomez-Preciado, Silvia Benito, et al.
European Heart Journal|November 6, 2020
Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differencesJob A J Verdonschot, Marco Merlo, Fernando Dominguez, et al.
Circulation|March 31, 2026
MR-ProADM Predicts Mortality and Heart Failure Events in ATTR Cardiac AmyloidosisBelén Peiró-Aventín, Elena Revuelta-Lopez, Mariana Brandao, et al.
International Journal of Neonatal Screening|October 19, 2020
CCHD Screening Implementation Efforts in Latin American Countries by the Ibero American Society of Neonatology (SIBEN)Augusto Sola, Susana Rodríguez, Alejandro Young, et al.
Pageof 8